Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered heterodimeric proteins

Engineered heterodimeric proteins

US Patent 11685776 · Granted Jun 27, 2023

Estimated economic value: $132,929,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD19 binding molecules and uses thereof2025
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their 2024
Production of T cell retargeting hetero-dimeric immunoglobulins2024
Production of T cell retargeting hetero-dimeric immunoglobulins2023
Methods of treating FGF21-associated disorders2023
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their 2023
FGF21 mimetic antibodies and uses thereof2023
Fc variant antibodies and their uses2022
Methods of treating FGF21-associated disorders2022
FGF21 mimetic antibodies and uses thereof2021
Hetero-dimeric immunoglobulins2017
Hetero-dimeric immunoglobulins2017